IL-2, IL-12, IL-15, IL-18, and IL-21 could promote NK cells entry into S and G2/M phases of the cell cycle in cancer patients or healthy subjects, and thus have been used to induce ex vivo NK cell proliferation (16, 29–33). Here, IL18 is linked to cancer.